Collectively, these findings suggest that IL-6 signaling orchestrates a coordinated increase in pro-inflammatory, autophagic, and FOXO-related pathways in NSCLC cells, potentially contributing to tumor cell adaptation and survival mechanisms for cancerous cells under inflammatory conditions. Here, IL6 is linked to non-small cell lung carcinoma.